December 16, 2021 by Chain Drug Review
AllianceRx Walgreens Prime, ANI Pharmaceuticals, Purified Cortrophin Gel, Tracey James
Pharmacy, Supplier News
ORLANDO — Purified Cortrophin Gel (repository corticotropin injection USP), an adrenocorticotropic hormone (ACTH)-based injection therapy for those with specific chronic autoimmune and inflammatory conditions, is available through AllianceRx Walgreens Prime. Cortrophin Gel is approved for certain chronic autoimmune disorders, including the treatment of acute exacerbations of multiple sclerosis (MS) and rheumatoid arthritis (RA), and excess urinary protein
May 19, 2020 by Chain Drug Review
AllianceRx Walgreens Prime, Lundbeck, Tracey James
Leading Headlines, Pharmacy
ORLANDO, Fla. — Lundbeck, a global pharmaceutical company specializing in brain diseases, has named AllianceRx Walgreens Prime one of only two specialty pharmacies to distribute its newest medication for the preventive treatment of migraine in adults. The medication, Vyepti (eptinezumab-jjmr), is the first and only intravenous preventive treatment for migraine. Migraine is a complex and incapacitating neurological
August 26, 2019 by Chain Drug Review
AllianceRx Walgreens Prime, limited distribution drugs (LDDs), Tracey James
August 26, 2019, News
ORLANDO, Fla. — AllianceRx Walgreens Prime has announced additional medicines available to patients with certain rare, chronic and complex conditions. Known as limited distribution drugs (LDDs), these specialty medicines treat certain types of multiple sclerosis (MS), Lambert-Eaton myasthenic syndrome (LEMS) and a form of non-Hodgkin’s lymphoma (NHL), among other complex conditions. Since last spring, the
August 12, 2019 by Chain Drug Review
AllianceRx Walgreens Prime, limited distribution drugs (LDDs), specialty medicines, Tracey James
Leading Headlines, Pharmacy
ORLANDO, Fla. — AllianceRx Walgreens Prime announced additional medicines available to patients with certain rare, chronic and complex conditions. Known as limited distribution drugs (LDDs), these specialty medicines treat certain types of multiple sclerosis (MS), Lambert-Eaton myasthenic syndrome (LEMS) and a form of non-Hodgkin’s lymphoma (NHL), among other complex conditions. Since last spring, the following
February 28, 2019 by Chain Drug Review
AllianceRx Walgreens Prime, Dane Hallberg, Probuphine (buprenorphine), Titan Pharmaceuticals, Tracey James
Featured Articles, Leading Headlines, Pharmacy
SOUTH SAN FRANCISCO, Calif. — Titan Pharmaceuticals announced Thursday the execution of a specialty pharmacy distribution and services agreement with AllianceRx Walgreens Prime that will expand patient access to treatment with Probuphine (buprenorphine) implant, Titan’s unique six-month maintenance treatment for opioid use disorder (OUD) in eligible patients. Titan expects the majority of Probuphine sales in the
February 13, 2019 by Chain Drug Review
AllianceRx Walgreens Prime, Cyramza (ramucirumab), Epclusa (sofosbuvir/velpatasvir), Harvoni (ledipasvir/sofosbuvir), limited-distribution drugs, Nuzyra (omadacycline), Portrazza (necitumumab), Probuphine (buprenorphine), Tracey James, Ultomiris (ravulizumab-cwvz)
Leading Headlines, Pharmacy
ORLANDO, Fla. — AllianceRx Walgreens Prime, a leading central specialty and home delivery pharmacy, can now offer new medicines to patients with certain rare, chronic and complex conditions. Known as limited distribution drugs, these hard-to-find medicines treat rare conditions such as advanced cancer of the stomach, community-acquired bacterial pneumonia (CABP), and opioid addiction, to name a
